308 related articles for article (PubMed ID: 11141475)
1. Increased expression of the interleukin-11 receptor and evidence of STAT3 activation in prostate carcinoma.
Campbell CL; Jiang Z; Savarese DM; Savarese TM
Am J Pathol; 2001 Jan; 158(1):25-32. PubMed ID: 11141475
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-11 receptor expression in primary ovarian carcinomas.
Campbell CL; Guardiani R; Ollari C; Nelson BE; Quesenberry PJ; Savarese TM
Gynecol Oncol; 2001 Feb; 80(2):121-7. PubMed ID: 11161848
[TBL] [Abstract][Full Text] [Related]
3. Coexpression of oncostatin M and its receptors and evidence for STAT3 activation in human ovarian carcinomas.
Savarese TM; Campbell CL; McQuain C; Mitchell K; Guardiani R; Quesenberry PJ; Nelson BE
Cytokine; 2002 Mar; 17(6):324-34. PubMed ID: 12061840
[TBL] [Abstract][Full Text] [Related]
4. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
Zerbini LF; Wang Y; Cho JY; Libermann TA
Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841
[TBL] [Abstract][Full Text] [Related]
5. C/EBPdelta is a downstream mediator of IL-6 induced growth inhibition of prostate cancer cells.
Sanford DC; DeWille JW
Prostate; 2005 May; 63(2):143-54. PubMed ID: 15486993
[TBL] [Abstract][Full Text] [Related]
6. Oncostatin M (OM) promotes the growth of DU 145 human prostate cancer cells, but not PC-3 or LNCaP, through the signaling of the OM specific receptor.
Mori S; Murakami-Mori K; Bonavida B
Anticancer Res; 1999; 19(2A):1011-5. PubMed ID: 10368647
[TBL] [Abstract][Full Text] [Related]
7. Stable expression of constitutively-activated STAT3 in benign prostatic epithelial cells changes their phenotype to that resembling malignant cells.
Huang HF; Murphy TF; Shu P; Barton AB; Barton BE
Mol Cancer; 2005 Jan; 4(1):2. PubMed ID: 15647107
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-22 activates STAT3 and induces IL-10 by colon epithelial cells.
Nagalakshmi ML; Rascle A; Zurawski S; Menon S; de Waal Malefyt R
Int Immunopharmacol; 2004 May; 4(5):679-91. PubMed ID: 15120652
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast growth factor-1 transcriptionally induces membrane type-1 matrix metalloproteinase expression in prostate carcinoma cell line.
Udayakumar TS; Nagle RB; Bowden GT
Prostate; 2004 Jan; 58(1):66-75. PubMed ID: 14673954
[TBL] [Abstract][Full Text] [Related]
10. Expression of interleukin-11 (IL-11) and IL-11 receptor alpha in human gastric carcinoma and IL-11 upregulates the invasive activity of human gastric carcinoma cells.
Nakayama T; Yoshizaki A; Izumida S; Suehiro T; Miura S; Uemura T; Yakata Y; Shichijo K; Yamashita S; Sekin I
Int J Oncol; 2007 Apr; 30(4):825-33. PubMed ID: 17332920
[TBL] [Abstract][Full Text] [Related]
11. Constitutive activation of Stat3 in human prostate tumors and cell lines: direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells.
Mora LB; Buettner R; Seigne J; Diaz J; Ahmad N; Garcia R; Bowman T; Falcone R; Fairclough R; Cantor A; Muro-Cacho C; Livingston S; Karras J; Pow-Sang J; Jove R
Cancer Res; 2002 Nov; 62(22):6659-66. PubMed ID: 12438264
[TBL] [Abstract][Full Text] [Related]
12. Expression of interleukin (IL)-11 and IL-11 receptor in human colorectal adenocarcinoma: IL-11 up-regulation of the invasive and proliferative activity of human colorectal carcinoma cells.
Yoshizaki A; Nakayama T; Yamazumi K; Yakata Y; Taba M; Sekine I
Int J Oncol; 2006 Oct; 29(4):869-76. PubMed ID: 16964382
[TBL] [Abstract][Full Text] [Related]
13. Stat3 activation in prostatic carcinomas.
Dhir R; Ni Z; Lou W; DeMiguel F; Grandis JR; Gao AC
Prostate; 2002 Jun; 51(4):241-6. PubMed ID: 11987152
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical analysis of the IL-6 family of cytokines and their receptors in benign, hyperplasic, and malignant human prostate.
Royuela M; Ricote M; Parsons MS; García-Tuñón I; Paniagua R; de Miguel MP
J Pathol; 2004 Jan; 202(1):41-9. PubMed ID: 14694520
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of potential Stat3-regulated genes in human breast cancer.
Hsieh FC; Cheng G; Lin J
Biochem Biophys Res Commun; 2005 Sep; 335(2):292-9. PubMed ID: 16081048
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of constitutively activated Stat3 signaling pathway suppresses growth of prostate cancer cells.
Ni Z; Lou W; Leman ES; Gao AC
Cancer Res; 2000 Mar; 60(5):1225-8. PubMed ID: 10728680
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandin E(2) stimulates prostatic intraepithelial neoplasia cell growth through activation of the interleukin-6/GP130/STAT-3 signaling pathway.
Liu XH; Kirschenbaum A; Lu M; Yao S; Klausner A; Preston C; Holland JF; Levine AC
Biochem Biophys Res Commun; 2002 Jan; 290(1):249-55. PubMed ID: 11779161
[TBL] [Abstract][Full Text] [Related]
18. Functional expression of the interleukin-11 receptor alpha-chain and evidence of antiapoptotic effects in human colonic epithelial cells.
Kiessling S; Muller-Newen G; Leeb SN; Hausmann M; Rath HC; Strater J; Spottl T; Schlottmann K; Grossmann J; Montero-Julian FA; Scholmerich J; Andus T; Buschauer A; Heinrich PC; Rogler G
J Biol Chem; 2004 Mar; 279(11):10304-15. PubMed ID: 14701802
[TBL] [Abstract][Full Text] [Related]
19. IL-10 signaling via IL-10E1 is dependent on tyrosine phosphorylation in the IL-10R alpha chain in human primary prostate cancer cell lines.
Stearns ME; Hu Y; Wang M
Oncogene; 2003 Jun; 22(24):3781-91. PubMed ID: 12802285
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of IL-10-induced STAT3 activation by 15-deoxy-Delta12,14-prostaglandin J2.
Ji JD; Kim HJ; Rho YH; Choi SJ; Lee YH; Cheon HJ; Sohn J; Song GG
Rheumatology (Oxford); 2005 Aug; 44(8):983-8. PubMed ID: 15840591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]